Uso concomitante de inibidor da glicoproteína IIb/IIa com estreptoquinase após angioplastia de salvamento sem sucesso

Sousa, José Marconi Almeida de; Severino, Leonardo; Rezende, Ederlon de Carvalho; Alencar, Jairon Nascimento; Lima, Valter Correia de; Hermann, Joäo Lourenço V.
Arq. bras. cardiol ; 78(4): 412-419, Apr. 2002. ilus
Artículo en Portugués, Inglés | LILACS | ID: lil-306446

Documentos relacionados

  1. Anticoagulation in coronary intervention.
  2. Risk-guided use of the direct thrombin inhibitor bivalirudin.
  3. [EXPERIENCE WITH THE USE OF EPTIFIBATIDE IN ACUTE CORONARY SYNDROME DURING CORONARY INTERVENTION IN PATIENTS OLDER AGE GROUP].
  4. Thrombin inhibition during PCI in heart failure patients.
  5. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
  6. Current Perspectives in Facilitated Angioplasty.
  7. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
  8. Risk factors for major bleeding and for minor bleeding after percutaneous coronary intervention in 634 consecutive patients with acute coronary syndromes.
  9. Primary percutaneous coronary intervention in acute myocardial infarction.
  10. [Changes and significance of P-selectin and PAC-1 in coronary heart disease before and after stenting].